Research Rheum

2007: A Remarkable Year for ARHP

Karen L. Kerr, MSN, NP, CPNP, APRN-BC | November 1, 2007

As I write this column, we are preparing to meet in Boston for the 2007 ACR/ARHP Annual Scientific Meeting, and my year as the ARHP president is coming to end. It has been a remarkable year for the ARHP, as we have made significant progress toward achieving the goals identified in our Long-Range Plan…

Become a Champion for RA

Staff | November 1, 2007

Ask any rheumatologist about the state of RA as a disease and you’re likely to get the same answer: There’s reason for great optimism and there’s a lot of work to be done.

Reckoning of a Presidential Year

Neal S. Birnbaum, MD | November 1, 2007

The past year was filled with accomplishments and I take away wonderful memories

Pursue Remission

Carol A. Wallace, MD | November 1, 2007

Disease remission should be the goal for all rheumatologists treating childhood arthritis

REF Fellowship Training Award Expanded

Staff | October 1, 2007

Workforce training should be at the forefront of every rheumatologist’s mind. The release of the 2006 Rheumatology Workforce Study, commissioned by the ACR, confirms that the current shortage of rheumatologists will continue to increase, affecting current and future patient care.

Innovative Educational Programs for Rheumatology APNs and PAs

Karen L. Kerr, MSN, NP, CPNP, APRN-BC | October 1, 2007

Arthritis and other rheumatic diseases affect more than 46 million adults and 300,000 children in the United States. With the aging of the U.S. population, the number of adults with rheumatic disease is expected to increase to 67 million by 2030.1 While the demand for rheumatology services is increasing, the supply of practicing rheumatologists is diminishing. The ACR Rheumatology Workforce Study (published earlier this year) predicts that there will be little or no increase in the number of practicing rheumatologists, resulting in a critical shortage of rheumatologists by 2020.

Enhanced Opportunities at the 2007 Meeting

Staff | October 1, 2007

The AMPC is using more translational components as a way of increasing the basic scientist’s interaction with clinicians, he explains. In keeping with this, the meeting will offer sessions on osteoclasts, implications for the development and treatment of osteoarthritis, T-cell subsets, and a year in review – all of which will be of interest to both the clinician and the basic researcher.